J&J | JNJ - Loan Capital

Stock Price
227.33
Daily Change
-0.46 -0.20%
Monthly
-6.25%
Yearly
45.44%
Q2 Forecast
222.63

J&J reported $37.53B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Abbott USD 29.64B 19.74B Mar/2026
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 25.96B 177M Mar/2026
Baxter International USD 9.47B 726M Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Biogen USD 6.29B 1.7M Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
CONMED USD 834.23M 18.78M Dec/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Eli Lilly USD 40.87B 5.6M Dec/2025
Gilead Sciences USD 22.13B 6M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Globus Medical USD 436K 9K Dec/2025
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merck USD 39.97B 6B Sep/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teva Pharmaceutical Industries USD 14.02B 971M Mar/2026
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026
Zoetis USD 9.04B 1.97B Dec/2025